In this regard, Defert et al. (2012) demonstrated in CGD animal models that NOX2-deficient mice respond to intradermal injection with β-glucans showing high levels of proinflammatory cytokines (TNFα, IL-6, and IL1β) in the skin lesions. The gene discussed is IL1B; the disease is chronic granulomatous disease.